Hepatitis B News and Research

Latest Hepatitis B News and Research

Breakthrough treatment reduces liver fibrosis in Hepatitis C patients

HCV infection is the underlying cause for chronic Hepatitis C (CHC), liver cirrhosis, and liver cancer or hepatocellular carcinoma (HCC). In 2019, over 2,90,000 people died of HCV-related diseases. Recent medical advancement made a new breakthrough treatment available for patients with hepatitis C. DAAs that block replication of HCV has dramatically transformed the treatment approach with around 90% effective anti-viral response rates. However, it is unclear whether DAAs impact the severity of disease burden caused by liver fibrosis.

21 Aug 2024

Global and Local Efforts to Take Action Against Hepatitis

In this interview, we explore global and local efforts to combat viral hepatitis with Lindsey Hiebert, Deputy Director of the Coalition for Global Hepatitis Elimination (CGHE), and James Amugsi, a Mandela Washington Fellow and Physician Assistant at Sandema Hospital in Ghana. Together, they provide valuable insights into the challenges, successes, and the importance of partnerships in the fight against hepatitis.

20 Aug 2024

State COVID-19 vaccine mandates increased vaccine uptake among healthcare workers in 2021

Researchers investigated the relationship between state COVID-19 vaccination mandates for healthcare workers and vaccination rates among them.

19 Aug 2024

Liver stiffness becomes crucial indicator for post-treatment hepatitis C risk assessment

Hepatitis C can be cured in almost all cases with modern medication. However, if advanced liver damage is already present at the time of cure, there is still a residual risk of liver cancer and complications of portal hypertension, such as abdominal fluid, bleeding from the digestive tract and confusion.

14 Aug 2024

Childhood vaccinations save trillions in societal costs while preventing millions of illnesses and deaths

Routine childhood vaccinations among children born between 1994 and 2023 have prevented millions of illnesses and deaths in the U.S., saving $540 billion in direct costs and $2.7 trillion in societal costs.

12 Aug 2024

Yogurt with probiotics and honey boosts gut bacteria but no digestive or cognitive benefits

A study in The Journal of Nutrition found that yogurt with B. animalis and honey increases probiotic levels but doesn't affect digestion, cognition, or mood.

6 Aug 2024

Review highlights the interplay of TGF-β and HIPPO pathways in liver regeneration and disease

The liver's ability to communicate with other organs is crucial for maintaining homeostasis, particularly through signaling pathways.

30 Jul 2024

Study reveals link between illicit fentanyl use and HCV transmission among people who inject drugs

An international team of researchers from University of California San Diego and el Colegio de la Frontera Norte in Mexico have revealed a significant association between the use of illicit fentanyl and the transmission of hepatitis C virus (HCV) among people who inject drugs in San Diego, California and Tijuana, Mexico.

30 Jul 2024

New study helps better understand the pathology of fatty liver disease MASH

A new study brings researchers closer to better understanding the pathology of the fatty liver disease MASH, which stands for metabolic dysfunction-associated steatohepatitis.

24 Jul 2024

Breakthrough malaria vaccines RTS,S and R21 poised to save thousands of lives

Research paper reviews the efficacy of the first licensed malaria vaccines, RTS,S and R21, highlighting their potential to significantly reduce childhood mortality and discussing future vaccine development strategies.

21 Jul 2024

Navigating adjuvant therapy options in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and is the third leading cause of cancer-related deaths.

16 Jul 2024

Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective management and improved survival rates.

16 Jul 2024

40% of US cancer cases linked to lifestyle choices

Nearly 40% of cancer cases and 44% of cancer deaths in 2019 were due to modifiable risk factors, with cigarette smoking as the leading cause. This study highlights the potential to significantly reduce cancer burden through lifestyle changes.

14 Jul 2024

Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors

A new study led by researchers at the American Cancer Society (ACS) finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old and older in the United States (or 713,340 cancer cases and 262,120 cancer deaths in 2019) could be attributed to modifiable risk factors, including cigarette smoking, excess body weight, alcohol consumption, physical inactivity, diet, and infections.

11 Jul 2024

Liver's defense mechanism hinders immunity in chronic hepatitis B, study reveals

In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus infected cells but are inactive. A team from the Technical University of Munich (TUM) has discovered that cells blood vessels in the liver start a "sleep timer" that switches off immune cells. Targeting this mechanism could be a starting point for immunotherapies.

11 Jul 2024

Hepatitis B News and Research

Latest Hepatitis B News and Research

Breakthrough treatment reduces liver fibrosis in Hepatitis C patients

Global and Local Efforts to Take Action Against Hepatitis

State COVID-19 vaccine mandates increased vaccine uptake among healthcare workers in 2021

Liver stiffness becomes crucial indicator for post-treatment hepatitis C risk assessment

Childhood vaccinations save trillions in societal costs while preventing millions of illnesses and deaths

Yogurt with probiotics and honey boosts gut bacteria but no digestive or cognitive benefits

Review highlights the interplay of TGF-β and HIPPO pathways in liver regeneration and disease

Study reveals link between illicit fentanyl use and HCV transmission among people who inject drugs

New study helps better understand the pathology of fatty liver disease MASH

Breakthrough malaria vaccines RTS,S and R21 poised to save thousands of lives

Navigating adjuvant therapy options in hepatocellular carcinoma

Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma

40% of US cancer cases linked to lifestyle choices

Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors

Liver's defense mechanism hinders immunity in chronic hepatitis B, study reveals

OraQuick HCV self-test receives WHO prequalification

How does SARS-CoV-2 cause lymphopenia when T cells barely express ACE-2 receptors?

Advancements in immunotherapy for hepatocellular carcinoma offer hope to patients

Fibrinogen-like protein 1 plays dual role in liver regeneration and hepatocellular carcinoma recurrence

Asia Pacific faces hepatitis crisis: Urgent action needed to meet WHO targets

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Hepatitis B News and Research

Latest Hepatitis B News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in